CYRN - CYREN Ltd.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
38,374
35,900
30,799
30,983
27,762
Cost of Revenue
15,357
14,540
11,899
10,042
8,323
Gross Profit
23,017
21,360
18,900
20,941
19,439
Operating Expenses
Research Development
16,751
16,116
9,825
8,656
8,930
Selling General and Administrative
24,048
24,545
22,837
17,459
15,044
Total Operating Expenses
40,799
40,661
32,662
26,115
23,974
Operating Income or Loss
-17,782
-19,301
-13,762
-5,174
-4,535
Interest Expense
-
255
2,134
60
274
Total Other Income/Expenses Net
268
-11
204
-982
132
Income Before Tax
-18,320
-19,567
-15,690
-6,215
-4,676
Income Tax Expense
-69
-153
-42
-2
123
Income from Continuing Operations
-18,251
-19,414
-15,648
-6,213
-4,799
Net Income
-18,251
-19,414
-15,648
-6,213
-4,799
Net Income available to common shareholders
-18,251
-19,414
-15,648
-6,213
-4,799
Reported EPS
Basic
-
-0.36
-0.40
-0.13
-0.14
Diluted
-
-0.36
-0.40
-0.13
-0.14
Weighted average shares outstanding
Basic
-
53,634
40,922
39,135
34,316
Diluted
-
53,634
40,922
39,135
34,316
EBITDA
-
-13,280
-8,507
-2,073
-1,516